The group’s principal activity is to produce therapies for cardi-metabolic, gastroenterological, and neurological disorders. The products of the group include CREON(R) MINIMICROSPHERES(R), EstroGel(R), LITHOBID(R) and LUVOX(R). The group operates from the United States.
